Skip to content

Drug interactions

Glyburide + Letermovir

Severity: Moderate

Glyburide and Letermovir: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Letermovir inhibits OATP1B1/3 and CYP2C8 and may raise exposure to glyburide, an OATP substrate. This can increase the risk of hypoglycemia. Letermovir labeling advises glucose monitoring with glyburide.

What this interaction means in plain words

Glyburide and Letermovir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Glyburide belongs to Endocrine; Letermovir belongs to Anti Virals.

Evidence level: Moderate

Why it happens

Letermovir inhibits hepatic OATP1B1/3 uptake and possibly CYP enzymes, increasing glyburide concentrations.

What to do

Monitor blood glucose frequently during letermovir therapy and reduce the glyburide dose if hypoglycemia occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Glyburide and Letermovir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Glyburide with Letermovir?

MediHelp rates the interaction as moderate. Glyburide and Letermovir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Letermovir inhibits OATP1B1/3 and CYP2C8 and may raise exposure to glyburide, an OATP substrate. This can increase the risk of hypoglycemia. Letermovir labeling advises glucose monitoring with glyburide.

How serious is the interaction between Glyburide and Letermovir?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose frequently during letermovir therapy and reduce the glyburide dose if hypoglycemia occurs.

What other medicines interact with Glyburide?

MediHelp also lists interactions of Glyburide with, for example, Bosentan, Cholic acid, Ciprofloxacin. The full list is on the Glyburide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in